Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - EPS
EPS NBIX - Neurocrine Biosciences, Inc.
2.56
LAST VALUE
64.16%
2 YEAR CAGR
63.37%
5 YEAR CAGR
19.03%
10 YEAR CAGR